Serum Level of Brain-Derived Neurotrophic Factor and Thrombotic Type Are Predictive of Cognitive Impairment in the Acute Period of Ischemic Strokes Patients

Table 1

Demographic and clinical characteristics of studied population.

Demographics	Groups		value
	Group 1 (n = 59)	Group 2 (n = 30)
Age, M ± SD	61.19 ± 9.61	57.84 ± 4.89
Sex, abs. (%)
M	37 (62.7%)	21 (70.0%)	χ^2 = 0.46 df = 2
F	22 (37.3%)	9 (30.0%)
Clinical type of stroke abs. (%)
Thrombotic	45 (76.3%)	—	—
Embolic	14 (23.7%)	—
NIHSS, M ± SD
1st day	7.02 ± 3.88	—	—
14th day	4.42 ± 3.39	—	—
value	0.038	—
BDNF level (pg/ml), M ± SD
1st day	307.87 ± 245.44	734.65 ± 417.53
14th day	470.94 ± 376.17	—
value	0.503	—
Cognitive impairment abs. (%)
1st day	32 (54.2%)	7 (23.3%)	χ^2 = 7.12, df = 1,
14th day	28 (47.6%)	—
value	Mac–Nemar’s χ^2 = 0.624, df = 1,	—